59

YORW

York Water ($YORW) Insider Trading Reality: 96% of 48 Purchases Are Automatic DRIP—$24.2M Rate Case Is the Real Catalyst

01/16/2026 20:20

Sentiment

C-Level

Summary

  • York Water ($YORW) draws attention with $24.2 million rate increase request; approval could boost annual revenue 30%
  • 96% of 48 insider purchases are automatic DRIP transactions, not strong bullish signal
  • Recent two-quarter earnings beat streak signals improving performance; Q3 EPS $0.43 beat $0.38 consensus
  • P/E of 24.28 shows reasonable valuation; $42 price target implies 20% upside potential
  • Stock crosses above 200-day moving average suggesting technical reversal; rate case outcome (late 2026-early 2027) is critical variable

POSITIVE

  • $24.2 million rate increase request could boost annual revenue from $77M to $100M if approved
  • Two consecutive quarters of earnings beats; Q3 EPS $0.43 exceeded consensus by 13%
  • Net margin 26.06% and operating margin 39.52% rank among sector's highest profitability
  • 27 consecutive years of dividend increases; 2.7% yield with sustainable 65% payout ratio
  • Major institutional buying: Vanguard +25.3%, BlackRock +9.8%; 49.86% institutional ownership
  • Crossed above 200-day moving average, signaling potential reversal of 18-month downtrend; up 14% from 52-week low
  • Beta of 0.73 indicates lower volatility than market; suitable for defensive portfolio positioning
  • Regulated monopoly business model provides stable cash flows; expanding 50,000+ customer base

NEGATIVE

  • 46 of 48 insider purchases (96%) are automatic DRIP transactions, weak signal of management conviction
  • Four consecutive quarters of earnings misses from Q3 2024-Q1 2025; improvement only in recent two quarters
  • Levered free cash flow of -$31.92M indicates ongoing capital pressure from capital-intensive business model
  • Revenue growth limited to 4-5% annually; ROE of 8.56% below sector average
  • Only one analyst covers stock, indicating minimal market attention; low trading volume
  • Rate case approval requires 12-18 months; lack of near-term catalysts
  • P/E of 24.28 exceeds sector average of 23.86; not in undervalued territory
  • Stock down 8% over 18 months (from $36.91 to $33.94); 18% below July 2024 peak of $41.31

Expert

York Water represents a classic regulated utility with stability and dividend appeal, but the key variable—rate case outcome—remains uncertain. Given that most insider purchases are automatic dividend reinvestments and growth remains limited, the stock suits defensive dividend investors, though caution is warranted until the rate decision is finalized.

Previous Closing Price

$33.94

+0.14(0.41%)

Average Insider Trading Data Over the Past Year

$31.44

Purchase Average Price

$0

Sale Average Price

$15.55K

Purchase Amount

$0

Sale Amount

Transaction related to News

Trading Date

Filing Date

Insider

Title

Type

Avg Price

Trans Value

01/16/2026

01/16/2026

Sale

$

York Water ($YORW) has caught investors' attention after filing a $24.2 million annual rate increase request in May 2025, based on $145 million in infrastructure investments. Founded in 1816 as America's oldest publicly traded water utility, York Water serves over 50,000 customers across south-central Pennsylvania with a market capitalization of $490 million. If approved, the filing would increase typical residential water bills by $14.16 per month and wastewater bills by $35.85 per month—representing approximately 31% of current annual revenue of $77 million. The Pennsylvania Public Utility Commission's review typically takes 12-18 months, with a decision expected in late 2026 or early 2027. Investors must carefully examine the 48 insider purchase transactions over the past 18 months. While superficially suggesting strong management confidence, closer analysis reveals a different picture. Forty-six of the 48 transactions (96%) were automatic purchases through the company's Dividend Reinvestment Plan (DRIP). DRIP represents pre-arranged, mechanical transactions where dividends automatically purchase shares rather than being paid in cash—not discretionary management decisions. Only three transactions were actual discretionary purchases: by officer Ashley Grimm, director Robert Lambert, and officer Suzanne Becker, totaling just $500-900 each. CEO Joseph Hand made multiple purchases, but nearly all were DRIP transactions, making them weak signals of conviction about future share price appreciation. This distinction is critical for investors who typically interpret insider buying as bullish. Earnings performance shows mixed trends. From Q3 2024 through Q1 2025, the company missed earnings estimates for four consecutive quarters. Q3 2024 EPS of $0.35 fell 22% short of the $0.45 consensus, while Q1 2025's $0.25 missed estimates of $0.33 by 24%. However, recent quarters show improvement: Q2 2025 delivered $0.35 EPS (versus $0.33 consensus) and Q3 2025 achieved $0.43 EPS (versus $0.38 estimate). Q3 revenue of $20.36 million grew 3.3% year-over-year, driven by customer base expansion and Distribution System Improvement Charges (DSIC). Net margin of 26.06% ranks among the sector's highest, with operating margin at 39.52%. However, annual revenue growth remains limited at 4-5%, return on equity of 8.56% trails sector averages, and levered free cash flow of -$31.92 million reflects ongoing capital intensity pressures. Valuation appears reasonable. The current P/E ratio of 24.28 slightly exceeds the utilities sector average of 23.86 but remains below the five-year average of 28.73. After declining 42% from 38.33 in 2021 to 22.14 in 2024, the multiple has recently rebounded. The forward P/E of 23.63 (based on 2026 estimated EPS of $1.43) suggests analyst price targets of $41-42 imply approximately 20% upside from current levels. However, coverage by only one analyst indicates limited market attention. Price-to-book of 2.05 and EV/EBITDA of 16.52 collectively point to neutral territory—neither overvalued nor undervalued. Technically, positive signals have emerged. The stock crossed above its 200-day moving average ($31.56-31.58) twice in January, suggesting potential reversal of an 18-month downtrend. After starting at $36.91 in June 2024, peaking at $41.31 in July, and declining to $30.39 in January 2025, shares have recovered to $33.94—up 14% from the 52-week low of $29.68. Institutional activity shows mixed signals: Vanguard increased holdings 25.3% in Q2 2025 and BlackRock added 9.8%, while State Street reduced its position 17.6%. Overall institutional ownership remains stable at 49.86%. Dividend appeal persists. The current 2.7% yield exceeds the bottom quartile of dividend-paying stocks, with a sustainable payout ratio of 65%. The company boasts 27 consecutive years of dividend increases, recently raising the quarterly dividend from $0.22 to $0.228. Annual dividend of $0.91 combined with a forward payout ratio of 59.48% suggests continued growth potential. Beta of 0.73 indicates lower volatility than the broader market, suitable for defensive portfolio construction. The investment thesis hinges on the rate case outcome. Approval would boost annual revenue from $77 million to approximately $100 million, potentially lifting EPS from $1.43 to $1.80-2.00. This scenario would compress the P/E to 17-19x, making the $42 price target achievable. Partial approval or delays would likely keep shares range-bound at $30-32. Outright rejection could trigger retracement to $28-30. Historically, regulators approve 60-80% of requested increases, suggesting a compromise of $15-19 million (annual revenue of $92-96 million) as realistic, supporting a $35-38 trading range. Near-term (1-6 months), expect neutral-to-slightly-bearish bias. Early-stage rate review provides no near-term catalysts, while earnings improvement remains tentative. However, after breaking above the 200-day average, shares are testing the $32-34 box range ceiling. Breaking through could target $36, while failure below $31 risks retesting $29. March 2026 earnings and rate case progress will determine direction. Longer-term (6+ months), cautious optimism is warranted. Positives include regulated utility business model stability, sustainable dividend growth, and $145 million infrastructure investment supporting rate base expansion. Negatives include limited 4-6% annual growth, rising climate adaptation investment burdens, and Pennsylvania population stagnation. Rate approval could deliver 8-10% total returns (including dividends), while rejection would limit returns to 3-5%. In conclusion, York Water stands at a crossroads. The 48 insider purchases mostly represent automatic dividend reinvestment rather than strong bullish conviction, while earnings improvement remains early-stage. The critical factor is the rate case decision expected in late 2026-early 2027. For defensive dividend investors willing to wait 12-18 months, accumulation at current levels merits consideration. Building initial positions at $31-32 and adjusting based on rate case progress represents a rational strategy. For short-term traders or those avoiding regulatory risk, waiting for clarity makes sense. Above $35, favor watching over buying; below $30, consider accumulation.

Sign up and access more data free.

With account, you can enjoy the following benefits:

  • Access advanced features of insider transaction screener.

  • Read insider transaction news without any limits.